Application of disaccharides alone and in combination, for the improvement of stability and particle properties of spray-freeze dried IgG

References

• Abdul-Fattah AM, Kalonia DS, Pikal MJ. 2007. The challenge of drying method selection for protein pharmaceuticals: product quality implications. J Pharm Sci. 96:1886–1916.
   PubMed Web of Science ®Google Scholar
• Agu RU, Ugwoke MI, Armand M, Kinget R, Verbeke N. 2001. The lung as a route for systemic delivery of therapeutic proteins and peptides. Respir Res. 2:198–209.
   PubMed Web of Science ®Google Scholar
• Ameri M, Maa Y-F. 2006. Spray drying of biopharmaceuticals: stability and process considerations. Drying Technol. 24:763–768.
   Web of Science ®Google Scholar
• Andya JD, Maa Y-F, Costantino HR, Nguyen P-A, Dasovich N, Sweeney TD, Hsu CC, Shire SJ. 1999. The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody. Pharmaceutical Res. 16:350–358.
   PubMed Web of Science ®Google Scholar
• Berger M, Shankar V, Vafai A. 2002. Therapeutic applications of monoclonal antibodies. Am J Med Sci. 324:14–30.
   PubMed Web of Science ®Google Scholar
• Bi R, Shao W, Wang Q, Zhang N. 2008. Spray-freeze-dried dry powder inhalation of insulin-loaded liposomes for enhanced pulmonary delivery. J Drug Target. 16:639–648.
   PubMed Web of Science ®Google Scholar
• Chang L, Shepherd D, Sun J, Ouellette D, Grant KL, Tang XC, Pikal MJ. 2005. Mechanism of protein stabilization by sugars during freeze-drying and storage: native structure preservation, specific interaction, and/or immobilization in a glassy matrix? J Pharm Sci. 94:1427–1444.
   PubMed Web of Science ®Google Scholar
• Chen L, Okuda T, Lu X-Y, Chan H-K. 2016. Amorphous powders for inhalation drug delivery. Adv Drug Delivery Rev. 100:102.
   PubMed Web of Science ®Google Scholar
• Chi EY, Krishnan S, Randolph TW, Carpenter JF. 2003. Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation. Pharm Res. 20:1325–1336.
   PubMed Web of Science ®Google Scholar
• Claussen IC, Ustad TS, Str⊘mmen I, Walde PM. 2007. Atmospheric freeze drying a review. Drying Technol. 25:947–957.
   Web of Science ®Google Scholar
• Costantino HR, Andya JD, Nguyen PA, Dasovich N, Sweeney TD, Shire SJ, Hsu CC, Maa YF. 1998. Effect of mannitol crystallization on the stability and aerosol performance of a spray-dried pharmaceutical protein, recombinant humanized anti-IgE monoclonal antibody. J Pharm Sci. 87:1406–1411.
   PubMed Web of Science ®Google Scholar
• Costantino HR, Carrasquillo KG, Cordero RA, Mumenthaler M, Hsu CC, Griebenow K. 1998. Effect of excipients on the stability and structure of lyophilized recombinant human growth hormone. J Pharm Sci. 87:1412–1420.
   PubMed Web of Science ®Google Scholar
• Costantino HR, Firouzabadian L, Wu C, Carrasquillo KG, Griebenow K, Zale SE, Tracy MA. 2002. Protein spray freeze drying. 2. Effect of formulation variables on particle size and stability. J Pharm Sci. 91:388–395.
   PubMed Web of Science ®Google Scholar
• D’Addio SM, Chan JG, Kwok PC, Prud’homme RK, Chan HK. 2012. Constant size, variable density aerosol particles by ultrasonic spray freeze drying. Int J Pharm. 427:185–191.
   PubMed Web of Science ®Google Scholar
• Ecker DM, Jones SD, Levine HL. 2015. The therapeutic monoclonal antibody market. MAbs. 7:9–14.
   PubMed Web of Science ®Google Scholar
• Engstrom JD, Simpson DT, Lai ES, Williams RO III, Johnston KP. 2007. Morphology of protein particles produced by spray freezing of concentrated solutions. Eur J Pharm Biopharm. 65:149–162.
   PubMed Web of Science ®Google Scholar
• Gagez AL, Cartron G. 2014. Obinutuzumab: a new class of anti-CD20 monoclonal antibody. Curr Opin Oncol. 26:484–491.
   PubMed Web of Science ®Google Scholar
• Kalden JR. 2000. The application of infliximab (Remicade), a chimeric monoclonal antibody, in the treatment of rheumatic diseases. Isr Med Assoc J. 2 Suppl:11–12.
   PubMedGoogle Scholar
• Katakam M, K Banga A. 1994. Aggregation of insulin and its prevention by carbohydrate excipients. PDA J Pharm Sci Technol. 49:160–165.
   Google Scholar
• Kim AI, Akers MJ, Nail SL. 1998. The physical state of mannitol after freeze-drying: effects of mannitol concentration, freezing rate, and a noncrystallizing cosolute. J Pharm Sci. 87:931–935.
   PubMed Web of Science ®Google Scholar
• Le VNP, Thi THH, Robins E, Flament MP. 2012. Dry powder inhalers: study of the parameters influencing adhesion and dispersion of fluticasone propionate. AAPS PharmSciTech. 13:477–484.
   PubMed Web of Science ®Google Scholar
• Maa Y-F, Nguyen P-A, Sweeney T, Shire SJ, Hsu CC. 1999. Protein inhalation powders: spray drying vs spray freeze drying. Pharm Res. 16:249–254.
   PubMed Web of Science ®Google Scholar
• Maa YF, Costantino HR, Nguyen PA, Hsu CC. 1997. The effect of operating and formulation variables on the morphology of spray-dried protein particles. Pharm Dev Technol. 2:213–223.
   PubMed Web of Science ®Google Scholar
• Maltesen MJ, van de Weert M. 2008. Drying methods for protein pharmaceuticals. Drug Discov Today Technol. 5:e81–e88.
   PubMedGoogle Scholar
• Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. 2010. Stability of protein pharmaceuticals: an update. Pharm Res. 27:544–575.
   PubMed Web of Science ®Google Scholar
• Maury M, Murphy K, Kumar S, Mauerer A, Lee G. 2005. Spray-drying of proteins: effects of sorbitol and trehalose on aggregation and FT-IR amide I spectrum of an immunoglobulin G. Eur J Pharm Biopharm. 59:251–261.
   PubMed Web of Science ®Google Scholar
• Mensink MA, Frijlink HW, van der Voort Maarschalk K, Hinrichs WLJ. 2017. How sugars protect proteins in the solid state and during drying (review): mechanisms of stabilization in relation to stress conditions. Eur J Pharmaceutics Biopharmaceutics. 114:288–295.
   PubMed Web of Science ®Google Scholar
• Ohtake S, Kita Y, Arakawa T. 2011. Interactions of formulation excipients with proteins in solution and in the dried state. Adv Drug Deliv Rev. 63:1053–1073.
   PubMed Web of Science ®Google Scholar
• Pikal MJ, Dellerman KM, Roy ML, Riggin RM. 1991. The effects of formulation variables on the stability of freeze-dried human growth hormone. Pharm Res. 8:427–436.
   PubMed Web of Science ®Google Scholar
• Pilcer G, Amighi K. 2010. Formulation strategy and use of excipients in pulmonary drug delivery. Int J Pharm. 392:1–19.
   PubMed Web of Science ®Google Scholar
• Pouya MA, Daneshmand B, Aghababaie S, Faghihi H, Vatanara A. 2018. Spray-freeze drying: a suitable method for aerosol delivery of antibodies in the presence of trehalose and cyclodextrins. AAPS PharmSciTech. 19(5):2247–2254.
   PubMed Web of Science ®Google Scholar
• Shoyele SA, Cawthorne S. 2006. Particle engineering techniques for inhaled biopharmaceuticals. Adv Drug Delivery Rev. 58:1009–1029.
   PubMed Web of Science ®Google Scholar
• Sonner C, Maa YF, Lee G. 2002. Spray-freeze-drying for protein powder preparation: particle characterization and a case study with trypsinogen stability. J Pharm Sci. 91:2122–2139.
   PubMed Web of Science ®Google Scholar
• Sou T, Kaminskas LM, Nguyen T-H, Carlberg R, McIntosh MP, Morton DAV. 2013. The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules. Eur J Pharmaceutics Biopharmaceutics. 83:234–243.
   PubMed Web of Science ®Google Scholar
• Tian F, Middaugh CR, Offerdahl T, Munson E, Sane S, Rytting JH. 2007. Spectroscopic evaluation of the stabilization of humanized monoclonal antibodies in amino acid formulations. Int J Pharmaceutics. 335:20–31.
   PubMed Web of Science ®Google Scholar
• Walters RH, Bhatnagar B, Tchessalov S, Izutsu K-I, Tsumoto K, Ohtake S. 2014. Next generation drying technologies for pharmaceutical applications. J Pharm Sci. 103:2673–2695.
   PubMed Web of Science ®Google Scholar
• Wanning S, Süverkrüp R, Lamprecht A. 2015. Pharmaceutical spray freeze drying. Int J Pharm. 488:136–153.
   PubMed Web of Science ®Google Scholar
• Webb SD, Golledge SL, Cleland JL, Carpenter JF, Randolph TW. 2002. Surface adsorption of recombinant human interferon-gamma in lyophilized and spray-lyophilized formulations. J Pharm Sci. 91:1474–1487.
   PubMed Web of Science ®Google Scholar